CLINICAL_TRIALS
trial_result
· 2024-06-25
Clinical Trial Update: A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma [Phase 1]
Summary
A Phase 1 study evaluating abemaciclib in combination with sunitinib for metastatic renal cell carcinoma has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brown University | Conditions: Renal Cell Carcinoma Metastatic | Phase 1 | Status: TERMINATED